Tezspire 110 mg/ml, Injektionslösung in einem Fertigpen

7680690800017 CH-69080 Injektionslösung in einem Fertigpen
Tezspire 110 mg/ml, Injektionslösung in einem Fertigpen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung in einem Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2026
Patient information leaflet
Français
26/09/2026
Patient information leaflet
Italien
26/09/2026

Detailed composition

Substance Quantity Type Category
tezepelumabum
210.0 MG Substance Wirkstoff (Principe actif)
prolinum
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrii hydroxidum
- Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1098.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2024

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
69080
Drug name
Tezspire, Injektionslösung in einem Fertigpen
Galenic form
INLFP
ATC Code
R03DX11
Authorization status
Z
Dispensing category
B
First authorization
23/08/2023
Authorization expiration date
22/08/2028
IT Number
03.04.5.
Domain
Human medicine
Field of application
Zusatztherapie bei schwerem Asthma, CRSwNP

Package details

Description (FR)
TEZSPIRE sol inj 210 mg/1.91ml stylo pré 1.91 ml
Description (DE)
TEZSPIRE Inj Lös 210 mg/1.91ml Fertpen 1.91 ml
Market launch
23/08/2023
Narcotic (BTM)
No
Buy us a coffee Explore the data